Real-World Assessment of Health Care Costs for Patients with Metastatic Pancreatic Cancer Following Initiation of First-Line Chemotherapy

por Bullock, Andrea, Rowan, Christopher G., Oestreicher, Nina, Yeganegi, Homa, Chiorean, E. Gabriela
Publicado 2020

The role of the folate pathway in pancreatic cancer risk

por Chittiboyina, Shirisha, Chen, Zhongxue, Chiorean, E. Gabriela, Kamendulis, Lisa M., Hocevar, Barbara A.
Publicado 2018

Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer

por Chiorean, E Gabriela, Von Hoff, Daniel, Wan, Yin, Margunato-Debay, Sandra, Botteman, Marc, Goldstein, David
Publicado 2018

The role of molecular testing in pancreatic cancer

por Zhen, David B., Safyan, Rachael A., Konick, Eric Q., Nguyen, Ryan, Prichard, Colin C., Chiorean, E. Gabriela
Publicado 2023

The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer

por Jia, Yanfei, Gu, Dongsheng, Wan, Jun, Yu, Beiqin, Zhang, Xiaoli, Chiorean, E. Gabriela, Wang, Yunshan, Xie, Jingwu
Publicado 2018

Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2

por LoRusso, Patricia, Venkatakrishnan, Karthik, Chiorean, E. Gabriela, Noe, Dennis, Wu, Jing-Tao, Sankoh, Serap, Corvez, Maria, Sausville, Edward A.
Publicado 2013

Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment

por Kim, Richard, Chiorean, E Gabriela, Amin, Manik, Rocha-Lima, Caio Max S, Gandhi, Jitendra, Harris, William P, Song, Tao, Portnoy, David
Publicado 2017

Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A ra...

por Chiorean, E. Gabriela, Picozzi, Vincent, Li, Chung‐Pin, Peeters, Marc, Maurel, Joan, Singh, Jaswinder, Golan, Talia, Blanc, Jean‐Frédéric, Chapman, Sonya C., Hussain, Anwar M., Johnston, Erica L., Hochster, Howard S.
Publicado 2023

Contribution of Environment and Genetics to Pancreatic Cancer Susceptibility

por Hocevar, Barbara A., Kamendulis, Lisa M., Pu, Xinzhu, Perkins, Susan M., Wang, Zheng-Yu, Johnston, Erica L., DeWitt, John M., Li, Lang, Loehrer, Patrick J., Klaunig, James E., Chiorean, E. Gabriela
Publicado 2014

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer

por Chiorean, E Gabriela, Von Hoff, Daniel D, Tabernero, Josep, El-Maraghi, Robert, Ma, Wen Wee, Reni, Michele, Harris, Marion, Whorf, Robert, Liu, Helen, Li, Jack Shiansong, Manax, Victoria, Romano, Alfredo, Lu, Brian, Goldstein, David
Publicado 2016

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer

por Chiorean, E Gabriela, Von Hoff, Daniel D, Tabernero, Josep, El-Maraghi, Robert, Wee Ma, Wen, Reni, Michele, Harris, Marion, Whorf, Robert, Liu, Helen, Shiansong Li, Jack, Manax, Victoria, Romano, Alfredo, Lu, Brian, Goldstein, David
Publicado 2016

Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer

por Goldstein, David, Von Hoff, Daniel D., Chiorean, E. Gabriela, Reni, Michele, Tabernero, Josep, Ramanathan, Ramesh K., Botteman, Marc, Aly, Abdalla, Margunato-Debay, Sandra, Lu, Brian, Louis, Chrystal U., McGovern, Desmond, Lee, Chee Khoon
Publicado 2020

Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors

por Luke, Jason J., Fakih, Marwan, Schneider, Charles, Chiorean, E. Gabriela, Bendell, Johanna, Kristeleit, Rebecca, Kurzrock, Razelle, Blagden, Sarah P., Brana, Irene, Goff, Laura W., O’Hayer, Kevin, Geschwindt, Ryan, Smith, Michael, Zhou, Feng, Naing, Aung
Publicado 2023

Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline

por Chiorean, E. Gabriela, Nandakumar, Govind, Fadelu, Temidayo, Temin, Sarah, Alarcon-Rozas, Ashley Efrain, Bejarano, Suyapa, Croitoru, Adina-Emilia, Grover, Surbhi, Lohar, Pritesh V., Odhiambo, Andrew, Park, Se Hoon, Garcia, Erika Ruiz, Teh, Catherine, Rose, Azmina, Zaki, Bassem, Chamberlin, Mary D.
Publicado 2020

KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas

por Diehl, Adam C, Hannan, Lindsay M, Zhen, David B, Coveler, Andrew L, King, Gentry, Cohen, Stacey A, Harris, William P, Shankaran, Veena, Wong, Kit M, Green, Steven, Ng, Natasha, Pillarisetty, Venu G, Sham, Jonathan G, Park, James O, Reddi, Deepti, Konnick, Eric Q, Pritchard, Colin C, Baker, Kelsey, Redman, Mary, Chiorean, E Gabriela
Publicado 2022

Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer

por Byrne, Katelyn T., Betts, Courtney B., Mick, Rosemarie, Sivagnanam, Shamilene, Bajor, David L., Laheru, Daniel A., Chiorean, E. Gabriela, O'Hara, Mark H., Liudahl, Shannon M., Newcomb, Craig, Alanio, Cécile, Ferreira, Ana P., Park, Byung S., Ohtani, Takuya, Huffman, Austin P., Väyrynen, Sara A., Dias Costa, Andressa, Kaiser, Judith C., Lacroix, Andreanne M., Redlinger, Colleen, Stern, Martin, Nowak, Jonathan A., Wherry, E. John, Cheever, Martin A., Wolpin, Brian M., Furth, Emma E., Jaffee, Elizabeth M., Coussens, Lisa M., Vonderheide, Robert H.
Publicado 2021

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

por Jamieson, Stephen M.F., Tsai, Peter, Kondratyev, Maria K., Budhani, Pratha, Liu, Arthur, Senzer, Neil N., Chiorean, E. Gabriela, Jalal, Shadia I., Nemunaitis, John J., Kee, Dennis, Shome, Avik, Wong, Way W., Li, Dan, Poonawala-Lohani, Nooriyah, Kakadia, Purvi M., Knowlton, Nicholas S., Lynch, Courtney R.H., Hong, Cho R., Lee, Tet Woo, Grénman, Reidar A., Caporiccio, Laura, McKee, Trevor D., Zaidi, Mark, Butt, Sehrish, Macann, Andrew M.J., McIvor, Nicholas P., Chaplin, John M., Hicks, Kevin O., Bohlander, Stefan K., Wouters, Bradly G., Hart, Charles P., Print, Cristin G., Wilson, William R., Curran, Michael A., Hunter, Francis W.
Publicado 2023